Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ankrin Therapeutics logo — Innovation in oncology

Ankrin Therapeutics

Innovation in oncology

Founded 2018 Denmark Denmark 5 employees Biotechnology, Health Care

General Information

Company Name Ankrin Therapeutics
Founded Year 2018
Location Denmark Denmark +1
Employees 5
Industries Biotechnology, Health Care
Social

Get notified when Ankrin Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Ankrin Therapeutics

Ankrin Therapeutics is a biotech start-up founded in 2018, with a focus on developing innovative drugs for cancer treatment. Their slogan, "Innovation in oncology," encapsulates the company's mission. Ankrin Therapeutics is dedicated to groundbreaking research in cancer biology, epigenetics, and DNA repair to develop novel therapeutic strategies against cancer. The company's approach is to leverage well-characterized protein targets, including kinases, to create first-in-class drugs targeting epigenetic regulators and homologous recombination. Ankrin Therapeutics operates in the Biotechnology and Health Care industries, positioning itself at the forefront of cutting-edge medical advancements. As of now, there is no available information regarding the headquarter location or recent investments and investors.

Taxonomy: Biotech, Cancer Treatment, Therapeutic Strategies, Oncology Research, Epigenetics, DNA Repair, Kinase Inhibitors, Protein Targets, Immuno-oncology, Drug Development

No funding data available for Ankrin Therapeutics yet.

Get notified when Ankrin Therapeutics raises funding

Ankrin Therapeutics Alternatives & Competitors

Ankrin Therapeutics vs
MediMabBio
MediMabBio Korea South

A biotechnology company that focuses on developing new therapeutic drugs targeting Oncology and Infl...

Non Equity Assistance
15 employees
Biotechnology, Health Care
Ankrin Therapeutics vs
Cure First
Cure First United States

Cure First is putting patients first by accelerating the identification of safer, more effective, an...

4 employees
Health Care
Ankrin Therapeutics vs
Oniria Therapeutics
Oniria Therapeutics Spain

A shift in cancer treatment methodology makes a world of difference.

Seed
16 employees
Biopharma, Biotechnology

FAQ About Ankrin Therapeutics

Innovation in oncology
Ankrin Therapeutics was founded in 2018.
Ankrin Therapeutics is headquartered in Denmark.
Ankrin Therapeutics operates in the following industries: Biotechnology, Health Care.
Ankrin Therapeutics has approximately 5 employees.
Top alternatives and competitors to Ankrin Therapeutics include MediMabBio, Cure First, Oniria Therapeutics, Camino Pharma, LLC, Caedo Oncology AS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ankrin Therapeutics and MediMabBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Ankrin Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy